BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9495725)

  • 1. Transrectal ultrasound appearance of hematolymphoid malignancies involving the prostate.
    Terris MK; Freiha FS
    Urology; 1998 Feb; 51(2):339-41. PubMed ID: 9495725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematolymphoid malignancies diagnosed at the time of radical prostatectomy.
    Terris MK; Hausdorff J; Freiha FS
    J Urol; 1997 Oct; 158(4):1457-9. PubMed ID: 9302142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operator is an independent predictor of detecting prostate cancer at transrectal ultrasound guided prostate biopsy.
    Lawrentschuk N; Toi A; Lockwood GA; Evans A; Finelli A; O'Malley M; Margolis M; Ghai S; Fleshner NE
    J Urol; 2009 Dec; 182(6):2659-63. PubMed ID: 19836804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
    Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
    J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of ultrasound guided and digitally directed transrectal biopsies of palpable prostatic abnormalities.
    Weaver RP; Noble MJ; Weigel JW
    J Urol; 1991 Mar; 145(3):516-8. PubMed ID: 1705293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.
    Djavan B; Waldert M; Zlotta A; Dobronski P; Seitz C; Remzi M; Borkowski A; Schulman C; Marberger M
    J Urol; 2001 Sep; 166(3):856-60. PubMed ID: 11490233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transrectal ultrasound imaging and ultrasound guided prostate biopsies in the detection of residual carcinoma in clinical stage A carcinoma of the prostate.
    Terris MK; McNeal JE; Stamey TA
    J Urol; 1992 Mar; 147(3 Pt 2):864-9. PubMed ID: 1371562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transrectal ultrasound appearance of transitional cell carcinoma involving the prostate.
    Terris MK; Villers A; Freiha FS
    J Urol; 1990 May; 143(5):952-6. PubMed ID: 2184257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two methods for transrectal ultrasound-guided biopsy of the prostate: systematic vs. guided for suspect echogenic lesion].
    Serrano-Brambila E; López-Sámano VA; Montoya-Martínez G; Espinoza-Guerrero X; González-Pérez J; Martínez-Cornelio A
    Cir Cir; 2008; 76(2):139-43. PubMed ID: 18492435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer.
    Terris MK; Freiha FS; McNeal JE; Stamey TA
    J Urol; 1991 Jul; 146(1):78-83; discussion 83-4. PubMed ID: 1711589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer.
    Levine MA; Ittman M; Melamed J; Lepor H
    J Urol; 1998 Feb; 159(2):471-5; discussion 475-6. PubMed ID: 9649265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of transrectal ultrasound in identifying local disease after radical prostatectomy.
    Kapoor DA; Wasserman NF; Zhang G; Reddy PK
    Urology; 1993 Jun; 41(6):594-7. PubMed ID: 7685958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis of prostatic carcinoma by random biopsies in 60 patients clinically negative but with PSA greater than 8.9 ng/ml].
    Bianchi A; Bottanelli A; Baroni G; Rovellini P; Sciaraffia G; Toia G; Marcelli G
    Arch Ital Urol Androl; 1997 Dec; 69(5):313-8. PubMed ID: 9477617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of transperineal ultrasound-guided prostate biopsies.
    Shinghal R; Terris MK
    Urology; 1999 Oct; 54(4):706-8. PubMed ID: 10510932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The continuing importance of transrectal ultrasound identification of prostatic lesions.
    Toi A; Neill MG; Lockwood GA; Sweet JM; Tammsalu LA; Fleshner NE
    J Urol; 2007 Feb; 177(2):516-20. PubMed ID: 17222623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
    Smart R
    N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.